Literature DB >> 17475364

Malignant mesothelioma following thoracic radiotherapy for lung cancer.

Sabrina M Witherby1, Kelly J Butnor, Steven M Grunberg.   

Abstract

As the number of long-term cancer survivors increases, secondary malignancies are becoming a greater clinical issue. Although some of these malignancies may be related to common environmental exposures, a significant number are considered to be therapy-related. Pleural malignant mesothelioma is a neoplasm that may be related to asbestos exposure or radiation exposure. Previous reports of pleural mesothelioma as a second malignancy have tended to follow radiotherapy for extra-thoracic malignancies such as Hodgkin's disease, breast cancer and Wilms' tumor. We report the case of a 66-year-old woman with no prior asbestos exposure who developed pleural mesothelioma 17 years after pneumonectomy and adjuvant radiation therapy for non-small cell lung cancer. Opacification of the lung field from prior therapy made determination of the diagnosis more challenging. Secondary malignancies such as mesothelioma should be considered in patients who develop unexplained symptoms even long after treatment of a primary tumor.

Entities:  

Mesh:

Year:  2007        PMID: 17475364     DOI: 10.1016/j.lungcan.2007.03.016

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  6 in total

Review 1.  Novel systemic therapy against malignant pleural mesothelioma.

Authors:  Michael R Mancuso; Joel W Neal
Journal:  Transl Lung Cancer Res       Date:  2017-06

2.  Risk of second tumor in intracranial germinoma patients treated with radiation therapy: the Johns Hopkins experience.

Authors:  Salma K Jabbour; Zhe Zhang; Dagmar Arnold; Moody D Wharam
Journal:  J Neurooncol       Date:  2008-09-24       Impact factor: 4.130

Review 3.  When the Diagnosis of Mesothelioma Challenges Textbooks and Guidelines.

Authors:  Giulio Rossi; Fabio Davoli; Venerino Poletti; Alberto Cavazza; Filippo Lococo
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241

4.  Post-irradiation pericardial malignant mesothelioma with deletion of p16: a case report.

Authors:  Yalda B Naeini; Ramir Arcega; Sharon Hirschowitz; Nagesh Rao; Haodong Xu
Journal:  Cancer Biol Med       Date:  2018-02       Impact factor: 4.248

5.  Malignant Pleural Mesothelioma in Patients Who Previously Received Radiotherapy for Their First Malignant Tumor.

Authors:  Ikuo Sekine; Yoshiyuki Yamamoto; Toshio Suzuki; Hideo Suzuki
Journal:  Intern Med       Date:  2020-10-14       Impact factor: 1.271

6.  The Association between Malignant Pleural Mesothelioma and Thoracic Radiation Therapy for Hodgkin's Lymphoma: The First Case Report in Japan.

Authors:  Koki Nakashima; Yoshiki Demura; Masahiro Oi; Mio Tabata; Toshihiko Tada; Kohei Shiozaki; Masaya Akai; Tamotsu Ishizuka
Journal:  Intern Med       Date:  2020-10-14       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.